Evidence map›Paper›PMID 36778773›Full record

ArticleHealth science reports2023

Venous thromboembolism in viral diseases: A comprehensive literature review.

Nasibeh Zerangian, Gisou Erabi, Mohadeseh Poudineh, Kosar Monajjem, Maryam Diyanati, Maryam Khanlari, Amirmohammad Khalaji, Diba Allafi, Arezoo Faridzadeh, Arian Amali and 7 more

Abstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. SevereFrontiers in medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Thrombosis in Critically Ill Influenza Patients: Incidence and Risk Factors.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nasibeh ZerangianHealth Education and Health Promotion, Department of Health Education and Health Promotion, School of Health Mashhad University of Medical Sciences Mashhad Iran.
Gisou ErabiStudent Research Committee Urmia University of Medical Sciences Urmia Iran.ORCID 0000-0001-6422-4474
Mohadeseh PoudinehSchool of Medicine Zanjan University of Medical Sciences Zanjan Iran.
Kosar MonajjemStudent Research Committee Tabriz University of Medical Sciences Tabriz Iran.
Maryam DiyanatiStudent Research Committee Rafsanjan University of Medical Sciences Rafsanjan Iran.
Maryam KhanlariStudent Research Committee Tabriz University of Medical Sciences Tabriz Iran.
Amirmohammad KhalajiSchool of Medicine Tehran University of Medical Sciences Tehran Iran.
Diba AllafiStudent Research Committee Urmia University of Medical Sciences Urmia Iran.
Arezoo FaridzadehDepartment of Immunology and Allergy, School of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Arian AmaliStudent Research Committee, Paramedical Department Islamic Azad University, Mashhad Branch Mashhad Iran.
Nilufar AlizadehDoctor of Medicine (MD), School of Medicine Iran University of Medical Sciences Tehran Iran.
Yasaman SalimiStudent Research Committee Kermanshah University of Medical Sciences Kermanshah Iran.
Sajjad Ghane EzabadiStudent's Scientific Research Center, School of Medicine Tehran University of Medical Sciences Tehran Iran.
Amir AbdiStudent Research Committee, School of Medicine, Tehran Medical Sciences Islamic Azad University Tehran Iran.
Zahra HasanabadiDoctor of Medicine (MD), School of Medicine Qazvin University of Medical Science Qazvin Iran.
Mahdie ShojaeiBaghiniMedical Informatics Research Center, Institute for Futures Studies in Health Kerman University of Medical Sciences Kerman Iran.
Niloofar DeraviStudent Research Committee, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venous thromboembolism (VTE) is known to be a common respiratory and/or cardiovascular complication in hospitalized patients with viral infections. Numerous studies have proven human immunodeficiency virus infection to be a prothrombotic condition. An elevated VTE risk has been observed in critically ill H1N1 influenza patients. VTE risk is remarkably higher in patients infected with the Hepatitis C virus in contrast to uninfected subjects. The elevation of D-dimer levels supported the association between Chikungunya and the Zika virus and the rise of clinical VTE risk. Varicella-zoster virus is a risk factor for both cellulitis and the consequent invasive bacterial disease which may take part in thrombotic initiation. Eventually, hospitalized patients infected with the coronavirus disease of 2019 (COVID-19), the cause of the ongoing worldwide pandemic, could mainly suffer from an anomalous risk of coagulation activation with enhanced venous thrombosis events and poor quality clinical course. Although the risk of VTE in nonhospitalized COVID-19 patients is not known yet, there are a large number of guidelines and studies on thromboprophylaxis administration for COVID-19 cases. This study aims to take a detailed look at the effect of viral diseases on VTE, the epidemiology of VTE in viral diseases, and the diagnosis and treatment of VTE.

Indexed as

COVID‐19venous thromboembolismviral diseasesVTE

Identifiers

PMID36778773
PMCPMC9900357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.